查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1762248

生物标记发现外包服务市场、规模、占有率、趋势、行业分析报告：依类型、治疗领域、发现阶段、最终用途、地区、市场预测2025-2034

Biomarker Discovery Outsourcing Services Market Size, Share, Trends, Industry Analysis Report: By Type, Therapeutic Area, Discovery Phase, End Use, and Region - Market Forecast, 2025-2034
出版日期: | 出版商: Polaris Market Research | 英文 128 Pages | 商品交期: 最快1-2个工作天内

价格

根据 Polaris Market Research 的一项新研究，全球生物标记发现外包服务市场预计到2034年将达到 839.3亿美元。本研究报告对当前的市场动态提供了详细的见解，并对未来的市场成长进行了分析。

生物标记发现外包服务包括与第三方签订合约，以识别、验证和开发在疾病诊断、药物开发和个人化医疗中发挥重要作用的生物标誌物。此类服务由合约研究组织（CRO）、生物技术公司和专业实验室提供，为製药和医疗保健公司提供下一代定序、蛋白质组学和生物资讯学等先进技术。外包生物标记发现可以帮助公司最佳化研发（R&D）效率、降低营运成本并加快新疗法的上市时间。随着对精准医疗和标靶治疗的日益关注，对此类服务的需求显着增加，因为生物标记可以帮助识别患者对治疗的特定反应并提高临床试验的成功率。由于研究合作的增加、医疗保健投资的增加以及基于生物标誌物的诊断技术的进步，生物标誌物发现外包服务市场稳步成长。

由于技术进步、强劲的製药业和支持性的监管框架，生物标誌物发现外包服务市场经历显着成长。关键驱动因素包括日益采用人工智慧（AI）和机器学习来增强生物标记分析，以及扩大服务组合以满足多样化的研究需求。开发商也优先考虑与药物开发商建立策略联盟，以提高效率和竞争力。人们对个人化医疗和生物标记驱动的药物开发的日益关注进一步加速市场发展，为疾病检测和治疗最佳化方面的创新解决方案创造了机会。随着精准医疗需求的成长，提供推动生物医学研究和治疗发展的尖端工具和服务的市场将持续发展。

生物标记发现外包服务市场报告重点

依类型划分，替代终点占据最大的市场占有率。替代终点可作为临床结果的间接衡量指标，使研究人员能够在药物开发过程中更有效地评估治疗的疗效和安全性。

基于治疗领域，肿瘤学占据生物标记发现外包服务市场主导地位。这是由于癌症发病率不断上升以及生物标记驱动的药物开发的日益普及。生物标记在早期癌症检测、预后预测和治疗选择的应用增加了该领域在临床研究中的重要性。

北美占有最大的市场占有率。这一优势源于对研发的大量投资、对精准医疗的关注以及製药公司和合约研究组织（CRO）之间的密切合作。

生物标记发现外包服务市场预计将以亚太地区最高的年复合成长率成长。这种快速扩张可以归因于製药公司研发活动的增加、临床试验活动的激增以及中国和印度等国家提供的经济高效的外包解决方案。

生物标记发现外包服务市场的主要参与者包括Laboratory Corporation of America Holdings（Labcorp）、Charles River Laboratories International, Inc.、Eurofins Scientific、Celerion、ICON plc、Parexel International（MA）Corporation、Proteome Sciences、Thermo Fisher Scientific Inc.、Evotec、WuXi AppTec、GenScript ProBio、Fujirebio Holdings Inc.。

目录

第1章 简介

第2章 执行摘要

第3章 研究方法

第4章 全球生物标记发现外包服务市场洞察

  • 市场概况
  • 生物标记发现外包服务市场动态
    • 驱动因素和机会
      • 慢性病盛行率不断上升
      • 组学技术的进步
    • 抑制因素和挑战
      • 生物标记验证的成本高且复杂
  • PESTEL 分析
  • 生物标记发现外包服务市场趋势
  • 价值链分析
  • COVID-19 影响分析

第5章 全球生物标记发现外包服务市场（依类型）

  • 主要调查结果
  • 简介
  • 预测性生物标记
  • 预后生物标记
  • 安全生物标记
  • 替代端点

第6章 全球生物标记发现外包服务市场（依治疗领域）

  • 主要调查结果
  • 简介
  • 肿瘤学
  • 神经病学
  • 心臟病学
  • 自体免疫疾病
  • 其他

第7章 全球生物标记发现外包服务市场（依发现阶段）

  • 主要调查结果
  • 简介
  • 生物标记识别
  • 生物标记验证
  • 生物标记分析
  • 生物标记组开发
  • 生物标记选择

第8章 全球生物标记发现外包服务市场（依最终用途）

  • 主要调查结果
  • 简介
  • 製药公司
  • 生技公司
  • 其他

第9章 全球生物标记发现外包服务市场（依地区）

  • 主要调查结果
  • 简介
    • 生物标记发现外包服务市场评估：地区，2020-2034
  • 北美
    • 北美：依类型，2020-2034年
    • 北美：依治疗领域，2020-2034年
    • 北美：依发现阶段，2020-2034年
    • 北美：依最终用途，2020-2034年
    • 美国
    • 加拿大
  • 欧洲
    • 欧洲：依类型，2020-2034年
    • 欧洲：依治疗领域，2020-2034年
    • 欧洲：依发现阶段，2020-2034年
    • 欧洲：依最终用途，2020-2034年
    • 英国
    • 法国
    • 德国
    • 义大利
    • 西班牙
    • 荷兰
    • 俄罗斯
    • 其他欧洲国家
  • 亚太地区
    • 亚太地区：依类型，2020-2034年
    • 亚太地区：依治疗领域，2020-2034年
    • 亚太地区：依发现阶段，2020-2034年
    • 亚太地区：依最终用途，2020-2034年
    • 中国
    • 印度
    • 马来西亚
    • 日本
    • 印尼
    • 韩国
    • 澳洲
    • 其他亚太地区
  • 中东和非洲
    • 中东和非洲：依类型，2020-2034年
    • 中东和非洲：依治疗领域，2020-2034年
    • 中东和非洲：依发现阶段，2020-2034年
    • 中东和非洲：依最终用途，2020-2034年
    • 沙乌地阿拉伯
    • 阿拉伯联合大公国
    • 以色列
    • 南非
    • 其他中东和非洲地区
  • 拉丁美洲
    • 拉丁美洲：依类型，2020-2034年
    • 拉丁美洲：依治疗领域，2020-2034年
    • 拉丁美洲：依发现阶段，2020-2034年
    • 拉丁美洲：依最终用途，2020-2034年
    • 墨西哥
    • 巴西
    • 阿根廷
    • 其他拉丁美洲国家

第10章 竞争格局

  • 扩张与收购分析
    • 扩张
    • 收购
  • 伙伴关係/协作/协议/公开

第11章 公司简介

  • Celerion
  • Charles River Laboratories International, Inc.
  • Eurofins Scientific
  • Evotec
  • Fujirebio Holdings Inc.
  • GenScript ProBio
  • ICON plc
  • Laboratory Corporation of America Holdings（Labcorp）
  • Parexel International（MA）Corporation
  • Proteome Sciences
  • Thermo Fisher Scientific Inc.
  • WuXi AppTec
Product Code: PM4075

The global biomarker discovery outsourcing services market size is expected to reach USD 83.93 billion by 2034, according to a new study by Polaris Market Research. The report "Biomarker Discovery Outsourcing Services Market Size, Share, Trends, Industry Analysis Report: By Type (Predictive Biomarkers, Prognostic Biomarkers, Safety Biomarkers, and Surrogate Endpoints), Therapeutic Area, Discovery Phase, End Use, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Biomarker discovery outsourcing services involve contracting third-party organizations to identify, validate, and develop biomarkers that play a crucial role in disease diagnosis, drug development, and personalized medicine. These services are offered by contract research organizations (CROs), biotechnology firms, and specialized laboratories, providing pharmaceutical and healthcare companies access to advanced technologies such as next-generation sequencing, proteomics, and bioinformatics. By outsourcing biomarker discovery, companies can optimize research and development (R&D) efficiency, reduce operational costs, and accelerate the time-to-market for new therapies. The growing focus on precision medicine and targeted therapies has significantly increased the demand for these services, as biomarkers help in identifying patient-specific responses to treatments and improving clinical trial success rates. The biomarker discovery outsourcing services market is witnessing steady growth due to increasing research collaborations, rising healthcare investments, and advancements in biomarker-based diagnostics.

The biomarker discovery outsourcing services market is experiencing significant growth, fueled by advancements in technology, a robust pharmaceutical sector, and supportive regulatory frameworks. Key drivers include the increasing adoption of artificial intelligence (AI) and machine learning to enhance biomarker analysis, as well as the expansion of service portfolios to meet diverse research needs. Companies are also prioritizing strategic collaborations with drug developers to improve efficiency and competitiveness. The rising focus on personalized medicine and biomarker-driven drug development is further accelerating market expansion, creating opportunities for innovative solutions in disease detection and treatment optimization. As demand for precision medicine grows, the market is poised for continued progress, offering cutting-edge tools and services to advance biomedical research and therapeutic development.

Biomarker Discovery Outsourcing Services Market Report Highlights

By type, surrogate endpoints hold the largest market share. Surrogate endpoints serve as indirect measures representing clinical outcomes, enabling researchers to assess treatment efficacy and safety more efficiently during drug development.

By therapeutic area, oncology dominates the biomarker discovery outsourcing services market, driven by the increasing prevalence of cancer and the growing adoption of biomarker-driven drug development. The use of biomarkers in early cancer detection, prognosis, and treatment selection enhances the segment's significance in clinical research.

North America holds the largest market share. This dominance is driven by substantial R&D investments, a strong emphasis on precision medicine, and robust collaborations between pharmaceutical companies and contract research organizations (CROs).

Asia Pacific is experiencing the highest biomarker discovery outsourcing services market CAGR. This rapid expansion is attributed to increasing pharmaceutical R&D activities, a surge in clinical trial operations, and cost-effective outsourcing solutions available in countries such as China and India.

The biomarker discovery outsourcing services market key players include Laboratory Corporation of America Holdings (Labcorp), Charles River Laboratories International, Inc., Eurofins Scientific, Celerion, ICON plc, Parexel International (MA) Corporation, Proteome Sciences, Thermo Fisher Scientific Inc., Evotec, WuXi AppTec, GenScript ProBio, and Fujirebio Holdings Inc

Polaris Market Research has segmented biomarker discovery outsourcing services market report based on type, therapeutic area, discovery phase, end use, and region:

By Type Outlook (Revenue-USD Billion, 2020-2034)

Predictive Biomarkers

Prognostic Biomarkers

Safety Biomarkers

Surrogate Endpoints

By Therapeutic Area Outlook (Revenue-USD Billion, 2020-2034)

Oncology

Neurology

Cardiology

Autoimmune Diseases

Others

By Discovery Phase Outlook (Revenue-USD Billion, 2020-2034)

Biomarker Identification

Biomarker Validation

Biomarker Profiling

Biomarker Panel Development

Biomarker Selection

By End Use Outlook (Revenue-USD Billion, 2020-2034)

Pharmaceutical Companies

Biotechnology Companies

Others

By Regional Outlook (Revenue-USD Billion, 2020-2034)

North America

US

Canada

Europe

Germany

France

UK

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

Suth Korea

Indnesia

Australia

Vietnam

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

Suth Africa

Rest of Middle East & Africa

Latin America

Mexic

Brazil

Argentina

Rest of Latin America

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Biomarker Discovery Outsourcing Services Market Insights

  • 4.1. Biomarker Discovery Outsourcing Services Market - Market Snapshot
  • 4.2. Biomarker Discovery Outsourcing Services Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Rising Prevalence of Chronic Diseases
      • 4.2.1.2. Advancements in Omics Technologies
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High cost and complexity of biomarker validation
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Biomarker Discovery Outsourcing Services Market Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Biomarker Discovery Outsourcing Services Market, by Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
  • 5.3. Predictive biomarkers
    • 5.3.1. Global Biomarker Discovery Outsourcing Services Market, by Predictive biomarkers, by Region, 2020-2034 (USD Billion)
  • 5.4. Prognostic biomarkers
    • 5.4.1. Global Biomarker Discovery Outsourcing Services Market, by Prognostic biomarkers, by Region, 2020-2034 (USD Billion)
  • 5.5. Safety biomarkers
    • 5.5.1. Global Biomarker Discovery Outsourcing Services Market, by Safety biomarkers, by Region, 2020-2034 (USD Billion)
  • 5.6. Surrogate endpoints
    • 5.6.1. Global Biomarker Discovery Outsourcing Services Market, by Surrogate endpoints, by Region, 2020-2034 (USD Billion)

6. Global Biomarker Discovery Outsourcing Services Market, by Therapeutic Area

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • 6.3. Oncology
    • 6.3.1. Global Biomarker Discovery Outsourcing Services Market, by Oncology, by Region, 2020-2034 (USD Billion)
  • 6.4. Neurology
    • 6.4.1. Global Biomarker Discovery Outsourcing Services Market, by Neurology, by Region, 2020-2034 (USD Billion)
  • 6.5. Cardiology
    • 6.5.1. Global Biomarker Discovery Outsourcing Services Market, by Cardiology, by Region, 2020-2034 (USD Billion)
  • 6.6. Autoimmune Diseases
    • 6.6.1. Global Biomarker Discovery Outsourcing Services Market, by Autoimmune Diseases, by Region, 2020-2034 (USD Billion)
  • 6.7. Others
    • 6.7.1. Global Biomarker Discovery Outsourcing Services Market, by Others, by Region, 2020-2034 (USD Billion)

7. Global Biomarker Discovery Outsourcing Services Market, by Discovery Phase

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
  • 7.3. Biomarker Identification
    • 7.3.1. Global Biomarker Discovery Outsourcing Services Market, by Biomarker Identification, by Region, 2020-2034 (USD Billion)
  • 7.4. Biomarker Validation
    • 7.4.1. Global Biomarker Discovery Outsourcing Services Market, by Biomarker Validation, by Region, 2020-2034 (USD Billion)
  • 7.5. Biomarker Profiling
    • 7.5.1. Global Biomarker Discovery Outsourcing Services Market, by Biomarker Profiling, by Region, 2020-2034 (USD Billion)
  • 7.6. Biomarker Panel Development
    • 7.6.1. Global Biomarker Discovery Outsourcing Services Market, by Biomarker Panel Development, by Region, 2020-2034 (USD Billion)
  • 7.7. Biomarker Selection
    • 7.7.1. Global Biomarker Discovery Outsourcing Services Market, by Biomarker Selection, by Region, 2020-2034 (USD Billion)

8. Global Biomarker Discovery Outsourcing Services Market, by End Use

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
  • 8.3. Pharmaceutical Companies
    • 8.3.1. Global Biomarker Discovery Outsourcing Services Market, by Pharmaceutical Companies, by Region, 2020-2034 (USD Billion)
  • 8.4. Biotechnology Companies
    • 8.4.1. Global Biomarker Discovery Outsourcing Services Market, by Biotechnology Companies, by Region, 2020-2034 (USD Billion)
  • 8.5. Others
    • 8.5.1. Global Biomarker Discovery Outsourcing Services Market, by Others, by Region, 2020-2034 (USD Billion)

9. Global Biomarker Discovery Outsourcing Services Market, by Geography

  • 9.1. Key Findings
  • 9.2. Introduction
    • 9.2.1. Biomarker Discovery Outsourcing Services Market Assessment, By Geography, 2020-2034 (USD Billion)
  • 9.3. Biomarker Discovery Outsourcing Services Market - North America
    • 9.3.1. North America: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
    • 9.3.2. North America: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
    • 9.3.3. North America: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
    • 9.3.4. North America: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
    • 9.3.5. Biomarker Discovery Outsourcing Services Market - US
      • 9.3.5.1. US: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
      • 9.3.5.2. US: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.3.5.3. US: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
      • 9.3.5.4. US: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
    • 9.3.6. Biomarker Discovery Outsourcing Services Market - Canada
      • 9.3.6.1. Canada: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
      • 9.3.6.2. Canada: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.3.6.3. Canada: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
      • 9.3.6.4. Canada: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
  • 9.4. Biomarker Discovery Outsourcing Services Market - Europe
    • 9.4.1. Europe: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
    • 9.4.2. Europe: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
    • 9.4.3. Europe: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
    • 9.4.4. Europe: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
    • 9.4.5. Biomarker Discovery Outsourcing Services Market - UK
      • 9.4.5.1. UK: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
      • 9.4.5.2. UK: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.4.5.3. UK: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
      • 9.4.5.4. UK: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
    • 9.4.6. Biomarker Discovery Outsourcing Services Market - France
      • 9.4.6.1. France: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
      • 9.4.6.2. France: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.4.6.3. France: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
      • 9.4.6.4. France: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
    • 9.4.7. Biomarker Discovery Outsourcing Services Market - Germany
      • 9.4.7.1. Germany: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
      • 9.4.7.2. Germany: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.4.7.3. Germany: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
      • 9.4.7.4. Germany: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
    • 9.4.8. Biomarker Discovery Outsourcing Services Market - Italy
      • 9.4.8.1. Italy: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
      • 9.4.8.2. Italy: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.4.8.3. Italy: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
      • 9.4.8.4. Italy: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
    • 9.4.9. Biomarker Discovery Outsourcing Services Market - Spain
      • 9.4.9.1. Spain: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
      • 9.4.9.2. Spain: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.4.9.3. Spain: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
      • 9.4.9.4. Spain: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
    • 9.4.10. Biomarker Discovery Outsourcing Services Market - Netherlands
      • 9.4.10.1. Netherlands: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
      • 9.4.10.2. Netherlands: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.4.10.3. Netherlands: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
      • 9.4.10.4. Netherlands: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
    • 9.4.11. Biomarker Discovery Outsourcing Services Market - Russia
      • 9.4.11.1. Russia: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
      • 9.4.11.2. Russia: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.4.11.3. Russia: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
      • 9.4.11.4. Russia: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
    • 9.4.12. Biomarker Discovery Outsourcing Services Market - Rest of Europe
      • 9.4.12.1. Rest of Europe: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
      • 9.4.12.2. Rest of Europe: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.4.12.3. Rest of Europe: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
      • 9.4.12.4. Rest of Europe: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
  • 9.5. Biomarker Discovery Outsourcing Services Market - Asia Pacific
    • 9.5.1. Asia Pacific: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
    • 9.5.2. Asia Pacific: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
    • 9.5.3. Asia Pacific: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
    • 9.5.4. Asia Pacific: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
    • 9.5.5. Biomarker Discovery Outsourcing Services Market - China
      • 9.5.5.1. China: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
      • 9.5.5.2. China: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.5.5.3. China: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
      • 9.5.5.4. China: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
    • 9.5.6. Biomarker Discovery Outsourcing Services Market - India
      • 9.5.6.1. India: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
      • 9.5.6.2. India: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.5.6.3. India: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
      • 9.5.6.4. India: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
    • 9.5.7. Biomarker Discovery Outsourcing Services Market - Malaysia
      • 9.5.7.1. Malaysia: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
      • 9.5.7.2. Malaysia: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.5.7.3. Malaysia: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
      • 9.5.7.4. Malaysia: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
    • 9.5.8. Biomarker Discovery Outsourcing Services Market - Japan
      • 9.5.8.1. Japan: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
      • 9.5.8.2. Japan: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.5.8.3. Japan: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
      • 9.5.8.4. Japan: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
    • 9.5.9. Biomarker Discovery Outsourcing Services Market - Indonesia
      • 9.5.9.1. Indonesia: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
      • 9.5.9.2. Indonesia: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.5.9.3. Indonesia: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
      • 9.5.9.4. Indonesia: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
    • 9.5.10. Biomarker Discovery Outsourcing Services Market - South Korea
      • 9.5.10.1. South Korea: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
      • 9.5.10.2. South Korea: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.5.10.3. South Korea: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
      • 9.5.10.4. South Korea: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
    • 9.5.11. Biomarker Discovery Outsourcing Services Market - Australia
      • 9.5.11.1. Australia: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
      • 9.5.11.2. Australia: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.5.11.3. Australia: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
      • 9.5.11.4. Australia: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
    • 9.5.12. Biomarker Discovery Outsourcing Services Market - Rest of Asia Pacific
      • 9.5.12.1. Rest of Asia Pacific: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
      • 9.5.12.2. Rest of Asia Pacific: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.5.12.3. Rest of Asia Pacific: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
      • 9.5.12.4. Rest of Asia Pacific: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
  • 9.6. Biomarker Discovery Outsourcing Services Market - Middle East & Africa
    • 9.6.1. Middle East & Africa: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
    • 9.6.2. Middle East & Africa: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
    • 9.6.3. Middle East & Africa: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
    • 9.6.4. Middle East & Africa: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
    • 9.6.5. Biomarker Discovery Outsourcing Services Market - Saudi Arabia
      • 9.6.5.1. Saudi Arabia: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
      • 9.6.5.2. Saudi Arabia: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.6.5.3. Saudi Arabia: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
      • 9.6.5.4. Saudi Arabia: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
    • 9.6.6. Biomarker Discovery Outsourcing Services Market - UAE
      • 9.6.6.1. UAE: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
      • 9.6.6.2. UAE: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.6.6.3. UAE: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
      • 9.6.6.4. UAE: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
    • 9.6.7. Biomarker Discovery Outsourcing Services Market - Israel
      • 9.6.7.1. Israel: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
      • 9.6.7.2. Israel: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.6.7.3. Israel: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
      • 9.6.7.4. Israel: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
    • 9.6.8. Biomarker Discovery Outsourcing Services Market - South Africa
      • 9.6.8.1. South Africa: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
      • 9.6.8.2. South Africa: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.6.8.3. South Africa: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
      • 9.6.8.4. South Africa: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
    • 9.6.9. Biomarker Discovery Outsourcing Services Market - Rest of Middle East & Africa
      • 9.6.9.1. Rest of Middle East & Africa: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
      • 9.6.9.2. Rest of Middle East & Africa: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.6.9.3. Rest of Middle East & Africa: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
      • 9.6.9.4. Rest of Middle East & Africa: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
  • 9.7. Biomarker Discovery Outsourcing Services Market - Latin America
    • 9.7.1. Latin America: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
    • 9.7.2. Latin America: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
    • 9.7.3. Latin America: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
    • 9.7.4. Latin America: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
    • 9.7.5. Biomarker Discovery Outsourcing Services Market - Mexico
      • 9.7.5.1. Mexico: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
      • 9.7.5.2. Mexico: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.7.5.3. Mexico: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
      • 9.7.5.4. Mexico: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
    • 9.7.6. Biomarker Discovery Outsourcing Services Market - Brazil
      • 9.7.6.1. Brazil: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
      • 9.7.6.2. Brazil: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.7.6.3. Brazil: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
      • 9.7.6.4. Brazil: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
    • 9.7.7. Biomarker Discovery Outsourcing Services Market - Argentina
      • 9.7.7.1. Argentina: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
      • 9.7.7.2. Argentina: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.7.7.3. Argentina: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
      • 9.7.7.4. Argentina: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
    • 9.7.8. Biomarker Discovery Outsourcing Services Market - Rest of Latin America
      • 9.7.8.1. Rest of Latin America: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
      • 9.7.8.2. Rest of Latin America: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.7.8.3. Rest of Latin America: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
      • 9.7.8.4. Rest of Latin America: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)

10. Competitive Landscape

  • 10.1. Expansion and Acquisition Analysis
    • 10.1.1. Expansion
    • 10.1.2. Acquisitions
  • 10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

  • 11.1. Celerion
    • 11.1.1. Company Overview
    • 11.1.2. Financial Performance
    • 11.1.3. Product Benchmarking
    • 11.1.4. Recent Development
  • 11.2. Charles River Laboratories International, Inc.
    • 11.2.1. Company Overview
    • 11.2.2. Financial Performance
    • 11.2.3. Product Benchmarking
    • 11.2.4. Recent Development
  • 11.3. Eurofins Scientific
    • 11.3.1. Company Overview
    • 11.3.2. Financial Performance
    • 11.3.3. Product Benchmarking
    • 11.3.4. Recent Development
  • 11.4. Evotec
    • 11.4.1. Company Overview
    • 11.4.2. Financial Performance
    • 11.4.3. Product Benchmarking
    • 11.4.4. Recent Development
  • 11.5. Fujirebio Holdings Inc.
    • 11.5.1. Company Overview
    • 11.5.2. Financial Performance
    • 11.5.3. Product Benchmarking
    • 11.5.4. Recent Development
  • 11.6. GenScript ProBio
    • 11.6.1. Company Overview
    • 11.6.2. Financial Performance
    • 11.6.3. Product Benchmarking
    • 11.6.4. Recent Development
  • 11.7. ICON plc
    • 11.7.1. Company Overview
    • 11.7.2. Financial Performance
    • 11.7.3. Product Benchmarking
    • 11.7.4. Recent Development
  • 11.8. Laboratory Corporation of America Holdings (Labcorp)
    • 11.8.1. Company Overview
    • 11.8.2. Financial Performance
    • 11.8.3. Product Benchmarking
    • 11.8.4. Recent Development
  • 11.9. Parexel International (MA) Corporation
    • 11.9.1. Company Overview
    • 11.9.2. Financial Performance
    • 11.9.3. Product Benchmarking
    • 11.9.4. Recent Development
  • 11.10. Proteome Sciences
    • 11.10.1. Company Overview
    • 11.10.2. Financial Performance
    • 11.10.3. Product Benchmarking
    • 11.10.4. Recent Development
  • 11.11. Thermo Fisher Scientific Inc.
    • 11.11.1. Company Overview
    • 11.11.2. Financial Performance
    • 11.11.3. Product Benchmarking
    • 11.11.4. Recent Development
  • 11.12. WuXi AppTec
    • 11.12.1. Company Overview
    • 11.12.2. Financial Performance
    • 11.12.3. Product Benchmarking
    • 11.12.4. Recent Development

List of Tables:

  • Table 1 Global Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
  • Table 2 Global Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 3 Global Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
  • Table 4 Global Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
  • Table 5 North America: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
  • Table 6 North America: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 7 North America: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
  • Table 8 North America: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
  • Table 9 U.S.: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
  • Table 10 U.S.: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 11 U.S.: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
  • Table 12 U.S.: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
  • Table 13 Canada: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
  • Table 14 Canada: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 15 Canada: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
  • Table 16 Canada: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
  • Table 17 Europe: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
  • Table 18 Europe: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 19 Europe: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
  • Table 20 Europe: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
  • Table 21 UK: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
  • Table 22 UK: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 23 UK: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
  • Table 24 UK: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
  • Table 25 France: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
  • Table 26 France: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 27 France: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
  • Table 28 France: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
  • Table 29 Germany: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
  • Table 30 Germany: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 31 Germany: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
  • Table 32 Germany: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
  • Table 33 Italy: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
  • Table 34 Italy: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 35 Italy: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
  • Table 36 Italy: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
  • Table 37 Spain: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
  • Table 38 Spain: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 39 Spain: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
  • Table 40 Spain: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
  • Table 41 Netherlands: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
  • Table 42 Netherlands: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 43 Netherlands: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
  • Table 44 Netherlands: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
  • Table 45 Russia: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
  • Table 46 Russia: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 47 Russia: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
  • Table 48 Russia: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
  • Table 49 Rest of Europe: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
  • Table 50 Rest of Europe: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 51 Rest of Europe: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
  • Table 52 Rest of Europe: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
  • Table 53 Asia Pacific: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
  • Table 54 Asia Pacific: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 55 Asia Pacific: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
  • Table 56 Asia Pacific: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
  • Table 57 China: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
  • Table 58 China: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 59 China: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
  • Table 60 China: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
  • Table 61 India: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
  • Table 62 India: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 63 India: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
  • Table 64 India: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
  • Table 65 Malaysia: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
  • Table 66 Malaysia: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 67 Malaysia: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
  • Table 68 Malaysia: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
  • Table 69 Japan: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
  • Table 70 Japan: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 71 Japan: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
  • Table 72 Japan: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
  • Table 73 Indonesia: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
  • Table 74 Indonesia: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 75 Indonesia: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
  • Table 76 Indonesia: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
  • Table 77 South Korea: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
  • Table 78 South Korea: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 79 South Korea: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
  • Table 80 South Korea: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
  • Table 81 Australia: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
  • Table 82 Australia: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 83 Australia: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
  • Table 84 Australia: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
  • Table 85 Rest of Asia Pacific: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
  • Table 86 Rest of Asia Pacific: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 87 Rest of Asia Pacific: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
  • Table 88 Rest of Asia Pacific: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
  • Table 89 Middle East & Africa: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
  • Table 90 Middle East & Africa: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 91 Middle East & Africa: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
  • Table 92 Middle East & Africa: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
  • Table 93 Saudi Arabia: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
  • Table 94 Saudi Arabia: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 95 Saudi Arabia: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
  • Table 96 Saudi Arabia: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
  • Table 97 UAE: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
  • Table 98 UAE: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 99 UAE: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
  • Table 100 UAE: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
  • Table 101 Israel: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
  • Table 102 Israel: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 103 Israel: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
  • Table 104 Israel: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
  • Table 105 South Africa: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
  • Table 106 South Africa: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 107 South Africa: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
  • Table 108 South Africa: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
  • Table 109 Rest of Middle East & Africa: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
  • Table 110 Rest of Middle East & Africa: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 111 Rest of Middle East & Africa: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
  • Table 112 Rest of Middle East & Africa: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
  • Table 113 Latin America: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
  • Table 114 Latin America: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 115 Latin America: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
  • Table 116 Latin America: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
  • Table 117 Mexico: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
  • Table 118 Mexico: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 119 Mexico: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
  • Table 120 Mexico: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
  • Table 121 Brazil: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
  • Table 122 Brazil: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 123 Brazil: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
  • Table 124 Brazil: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
  • Table 125 Argentina: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
  • Table 126 Argentina: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 127 Argentina: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
  • Table 128 Argentina: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
  • Table 129 Rest of Latin America: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
  • Table 130 Rest of Latin America: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 131 Rest of Latin America: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
  • Table 132 Rest of Latin America: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)

List of Figures:

  • Figure 1. Global Biomarker Discovery Outsourcing Services Market, 2020-2034 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Type
  • Figure 7. Global Biomarker Discovery Outsourcing Services Market, by Type, 2024 & 2034 (USD Billion)
  • Figure 8. Market by Therapeutic Area
  • Figure 9. Global Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2024 & 2034 (USD Billion)
  • Figure 10. Market by Discovery Phase
  • Figure 11. Global Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2024 & 2034 (USD Billion)
  • Figure 12. Market by End Use
  • Figure 13. Global Biomarker Discovery Outsourcing Services Market, by End Use, 2024 & 2034 (USD Billion)